UNSPSC 51332801: Chlorproethazine

This classification denotes an anticholinergic agent with the molecular formula C19H23ClN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 960NX27Z07, chemically known as 10h-phenothiazine-3-propanamine, 2-chloro-n,n-diethyl-, monohydrochloride but generally known as chlorproethazine, which bears US NIH Compound Identifier 65750. European Medicines Agency schedules Chlorproethazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06206MIG.

UNSPSC 51332801 Chlorproethazine is a Commodity code that in practice encompasses pharmaceutical products and related medical supplies procured by state and local health agencies, though the single recent opportunity on record does not directly align with the code's nominal scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding; the solicitation required quarterly deliveries to the Seminole County Community Health Building with shipping costs included in vendor proposals, E-Verify compliance, drug-free workplace certification, and maintenance of workers' compensation, commercial general liability, and professional liability insurance. The contract carried a two-year initial term with an optional one-year renewal and was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The code shows limited recent activity in the state and local procurement space with little evidence of routine solicitation across multiple jurisdictions.

The recent opportunity is concentrated in Florida, specifically Seminole County. The solicitation closed on July 26, 2023, with electronic bidding through the county's e-Procurement Portal and a three-month probationary termination clause. No explicit set-aside designations for disadvantaged enterprises were stated. The mismatch between the code's pharmaceutical focus and the actual procurement of naloxone and drug deactivation systems suggests this code may not be the primary taxonomy path for medical and pharmaceutical supplies in state and local procurement, or that jurisdictions tag these health-agency purchases inconsistently across the UNSPSC hierarchy.